These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 29782749)

  • 1. [INFLUENCE OF ETHINYLESTRADIOL - GESTODENE COMBINATION ON THE FUNCTIONAL ACTIVITY AND EXPRESSION OF P-GLYCOPROTEIN.].
    Yakusheva EN; Kotlyarova AA; Shul'kin AV; Vinogradov IY; Popova NM
    Eksp Klin Farmakol; 2016; 79(6):15-19. PubMed ID: 29782749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Simultaneous determination of gestodene, etonogestrel and ethinylestradiol in plasma by LC-MS/MS following derivatization].
    Liu XF; Ding CG; Ge QH; Zhou Z; Zhi XJ
    Yao Xue Xue Bao; 2010 Jan; 45(1):87-92. PubMed ID: 21351455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum resistin levels in women taking combined oral contraceptives containing desogestrel or gestodene.
    Rechberger T; Tomaszewski J; Pieprzowska-Białek A; Kulik-Rechberger B; Skorupski P
    Contraception; 2004 Jun; 69(6):477-80. PubMed ID: 15157792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open-label, two-period comparative study on pharmacokinetics and safety of a combined ethinylestradiol/gestodene transdermal contraceptive patch.
    Zhang C; Li H; Xiong X; Zhai S; Wei Y; Zhang S; Zhang Y; Xu L; Liu L
    Drug Des Devel Ther; 2017; 11():725-731. PubMed ID: 28331292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive.
    Saano V; Glue P; Banfield CR; Reidenberg P; Colucci RD; Meehan JW; Haring P; Radwanski E; Nomeir A; Lin CC
    Clin Pharmacol Ther; 1995 Nov; 58(5):523-31. PubMed ID: 7586946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraceptives containing ethinyl estradiol and gestodene markedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2.
    Granfors MT; Backman JT; Laitila J; Neuvonen PJ
    Clin Pharmacol Ther; 2005 Oct; 78(4):400-11. PubMed ID: 16198659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives containing 20 or 30 micrograms ethinylestradiol and 150 micrograms desogestrel: pharmacokinetics and pharmacodynamic parameters.
    Jung-Hoffmann C; Fitzner M; Kuhl H
    Horm Res; 1991; 36(5-6):238-46. PubMed ID: 1823082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and application of a radioimmunoassay of the new progestagen gestodene.
    Nieuweboer B; Tack J; Täuber U; Hümpel M; Wendt H
    Contraception; 1989 Sep; 40(3):313-23. PubMed ID: 2766723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efflux transport is an important determinant of ethinylestradiol glucuronide and ethinylestradiol sulfate pharmacokinetics.
    Zamek-Gliszczynski MJ; Day JS; Hillgren KM; Phillips DL
    Drug Metab Dispos; 2011 Oct; 39(10):1794-800. PubMed ID: 21708882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood coagulation with a combination pill containing gestodene and ethinyl estradiol.
    Bonnar J; Daly L; Carroll E
    Int J Fertil; 1987; 32 Suppl():21-8. PubMed ID: 2906344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transporter studies with the 3-O-sulfate conjugate of 17alpha-ethinylestradiol: assessment of human liver drug transporters.
    Han YH; Busler D; Hong Y; Tian Y; Chen C; Rodrigues AD
    Drug Metab Dispos; 2010 Jul; 38(7):1072-82. PubMed ID: 20360302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and serum protein binding of gestodene and 3-keto-desogestrel in women after single oral administration of two different contraceptive formulations.
    Kuhnz W; Schütt B; Power J; Back DJ
    Arzneimittelforschung; 1992 Sep; 42(9):1139-41. PubMed ID: 1445482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sex differences of P-glycoprotein functional activity and expression in rabbits].
    Iakusheva EN; Chernykh IV; Shchul'kin AV; Kotliarova AA; Nikiforov AA
    Ross Fiziol Zh Im I M Sechenova; 2014 Aug; 100(8):944-52. PubMed ID: 25682686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and protein binding of gestodene under treatment with a low-dose combination oral contraceptive for three months.
    Dibbelt L; Knuppen R; Kuhnz W; Jütting G
    Arzneimittelforschung; 1992 Sep; 42(9):1146-52. PubMed ID: 1445484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body weight change during use of a monophasic oral contraceptive containing 20 microg ethinylestradiol and 75 microg gestodene with a comparison of the women who completed versus those who prematurely discontinued intake.
    Endrikat J; Gerlinger C; Cronin M; Wessel J; Ruebig A; Rosenbaum P; Düsterberg B
    Eur J Contracept Reprod Health Care; 2001 Dec; 6(4):199-204. PubMed ID: 11848649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-layer weekly sustained release transdermal patch containing gestodene and ethinylestradiol.
    Gao Y; Liang J; Liu J; Xiao Y
    Int J Pharm; 2009 Jul; 377(1-2):128-34. PubMed ID: 19463930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure stability in a normotensive population during intake of a monophasic oral contraceptive containing 20 microg ethinylestradiol and 75 g gestodene.
    Endrikat J; Gerlinger C; Cronin M; Ruebig A; Schmidt W; Düsterberg B
    Eur J Contracept Reprod Health Care; 2001 Sep; 6(3):159-66. PubMed ID: 11763980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological and endocrine profiles of gestodene.
    Spona J; Huber J
    Int J Fertil; 1987; 32 Suppl():6-14. PubMed ID: 2906347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexual behavior of women taking low-dose oral contraceptive containing 15 microg ethinylestradiol/60 microg gestodene.
    Caruso S; Agnello C; Intelisano G; Farina M; Di Mari L; Cianci A
    Contraception; 2004 Mar; 69(3):237-40. PubMed ID: 14969672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.